Philippines Wound Care Market by Product (Advanced Wound Care, Surgical Wound Care, and Traditional/Basic Wound Care), Application (Chronic Wounds and Acute Wounds), and End User (Hospitals and Community Health Service Centers): Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3419
- Pages: 165
-
Format:
The Philippines wound care market size was valued at $51 million in 2017, and is projected to reach $85 million by 2025, registering a CAGR of 6.5% during the forecast period.
Traditional wound care and advanced wound care products are used in the treatment of acute and chronic wounds. Advanced wound care has emerged as a standard solution for the treatment of chronic wounds, which need substantial time to heal and incur high cost. Traditional wound care products are being increasingly substituted with advanced wound care products due to their efficiency and effectiveness to treat wounds by enabling faster healing. Increase in the number of surgical procedures and spiraling demand for technologically advanced surgical procedures such as minimally invasive surgeries and laparoscopic surgeries drive the growth of the market.
The growth of the market is attributed to the rapid growth in geriatric population & favorable demographics; rise in incidence of diabetes, obesity, and chronic conditions; technological advancements to deal with complex wounds; and increase in awareness to reduce healthcare costs. However, reluctance in adoption of new technologies restrain the growth of the market. Increased focus toward advanced treatment protocols and significant unmet needs in wound care act as growth opportunities for the market.
The Philippines wound care market is segmented based on product type, application, and end user. By product type, the market is categorized into advanced wound care, surgical wound care, and traditional/basic wound care. Advanced wound care is sub-segmented into infection management, exudate management, active wound care, and therapy devices. Infection management is the leading segment in the global market. It is further classified into silver dressings, non-silver dressings, and collagens. Exudate management is sub divided into hydrocolloid dressings, foam dressings, alginate dressings, and hydrogel dressings. Active wound care is further divided into skin substitutes and growth factors. Therapy devices is sub segmented into negative pressure wound therapy (NPWT), oxygen & hyperbaric oxygen equipment, electromagnetic therapy devices, and others. Surgical wound is further categorized into sutures & staples, tissue adhesives, sealants, & glues, and anti-infective dressings. Tissue adhesives, sealants, & glues are further divided into fibrin-based sealants, collagen-based sealants, and synthetic adhesives/glues. Traditional/basic wound care are sub segmented into medical tapes, dressings, and cleansing agents. Based on application, the market is bifurcated into chronic wound care and acute wound care. The end users of the market are hospitals and community centers.
KEY BENEFITS FOR STAKEHOLDERS
The report provides an in-depth analysis of the market and the estimated revenues generated during the forecast period.
Quantitative analysis of the current trends and future estimations is provided to help the manufacturers of wound care products to analyze the market.
The entire projections in the report are based on analysis of the current market trends and highlight the market potential for the period from 2018 to 2025, in terms of value.
The report conducts extensive analysis of the industry by closely following key product positioning and monitoring the top contenders within the market framework.
The report provides quantitative and qualitative market trends to assist stakeholders to understand the situations prevailing in the market.
KEY MARKET SEGMENTS
By Product
Advanced Wound Care
o Infection Management
Silver Wound Dressings
Non-silver Wound Dressings
Collagen Dressings
o Exudate Management
Hydrocolloid Dressings
Foam Dressings
Alginate Dressings
Hydrogel Dressings
o Active Wound Care
Skin Substitutes
Growth Factors
o Therapy Devices
Negative Pressure Wound Therapy (NPWT)
Oxygen & Hyperbaric Oxygen Equipment
Electromagnetic Therapy Devices
Others
Surgical Wound Care
o Sutures & Staples
o Tissue Adhesives, Sealants, & Glues
Fibrin-Based Sealants
Collagen-Based Sealants
Synthetic Adhesives/Glues
o Anti-Infective Dressings
Traditional/Basic Wound Care
o Medical Tapes
o Dressings
o Cleansing Agents
By Application
Chronic Wounds
o Pressure Ulcers
o Diabetic Foot Ulcers
o Venous Leg Ulcers
o Arterial Ulcers
Acute Wounds
o Burns & Trauma
o Surgical Wounds
By End User
Hospitals
Community Health Service Centers
LIST OF KEY PLAYERS PROFILED IN THE REPORT
3M Company
Smith & Nephew Plc.
Coloplast A/S
Medtronic Plc
ConvaTec Group Plc
Cardinal Health, Inc.
BSN Medical GmbH
Mundipharma International Ltd.
B. Braun Melsungen AG
Urgo Medical
Chapter: 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter: 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS
2.2. CXO PERSPECTIVE
Chapter: 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. TOP PLAYER POSITIONING, 2017
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Rise in geriatric population and favorable demographics
3.5.1.2. Growth in incidence of diabetes, obesity, and chronic conditions
3.5.1.3. Technological advancements to deal with complex wounds
3.5.1.4. Increase in awareness to reduce healthcare costs
3.5.2. Restraints
3.5.2.1. Reluctance in adoption of new technologies
3.5.2.2. Development of substitute products and lack of sufficient evidence
3.5.3. Opportunities
3.5.3.1. Increase in focus towards advanced treatment protocols
3.6. REGULATORY ANALYSIS
3.6.1. Regulatory approval for medical products in the Philippines
3.6.1.1. License To Operate (LTO):
3.6.1.2. Product Registration:
3.6.1.2.1. General Guidelines
3.6.1.2.2. Specific Guidelines
3.6.1.2.3. Legal Requirements for Application for the Notification of Medical Devices under Class A and Registration of Medical Devices under Classes B, C and D
3.7. CLINICAL TRIALS FOR WOUND CARE PRODUCTS
Chapter: 4: PHILIPPINES WOUND CARE MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ADVANCED WOUND CARE
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.2.1. Infection management
4.2.2.1.1. Market size and forecast
4.2.2.1.1.1. Silver wound dressings
4.2.2.1.1.1.1.Market size and forecast
4.2.2.1.1.2. Non-silver dressings
4.2.2.1.1.2.1.Market size and forecast
4.2.2.1.1.3. Collagen dressings
4.2.2.1.1.3.1.Market size and forecast
4.2.2.2. Exudate management
4.2.2.2.1. Market size and forecast
4.2.2.2.1.1. Hydrocolloid dressings
4.2.2.2.1.1.1.Market size and forecast
4.2.2.2.1.2. Foam dressings
4.2.2.2.1.2.1.Market size and forecast
4.2.2.2.1.3. Alginate dressings
4.2.2.2.1.3.1.Market size and forecast
4.2.2.2.1.4. Hydrogel dressings
4.2.2.2.1.4.1.Market size and forecast
4.2.2.3. Active wound care
4.2.2.3.1. Market size and forecast
4.2.2.3.1.1. Skin substitutes
4.2.2.3.1.1.1.Market size and forecast
4.2.2.3.1.2. Growth factors
4.2.2.3.1.2.1.Market size and forecast
4.2.2.4. Therapy device
4.2.2.4.1. Market size and forecast
4.2.2.4.1.1. Negative pressure wound therapy (NPWT)
4.2.2.4.1.1.1.Market size and forecast
4.2.2.4.1.2. Oxygen & hyperbaric oxygen equipment
4.2.2.4.1.2.1.Market size and forecast
4.2.2.4.1.3. Electromagnetic therapy devices
4.2.2.4.1.3.1.Market size and forecast
4.2.2.4.1.4. Others
4.2.2.4.1.4.1.Market size and forecast
4.3. SURGICAL WOUND CARE
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.2.1. Sutures & staples
4.3.2.1.1. Market size and forecast
4.3.2.2. Tissue adhesives, sealants, & glues
4.3.2.2.1. Market size and forecast
4.3.2.2.1.1. Fibrin-based sealants
4.3.2.2.1.1.1.Market size and forecast
4.3.2.2.1.2. Collagen-based sealants
4.3.2.2.1.2.1.Market size and forecast
4.3.2.2.1.3. Synthetic adhesives/glues
4.3.2.2.1.3.1.Market size and forecast
4.3.2.3. Anti-infective dressing
4.3.2.3.1. Market size and forecast
4.4. TRADITIONAL/BASIC WOUND CARE
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.2.1. Medical tapes
4.4.2.1.1. Market size and forecast
4.4.2.2. Dressings
4.4.2.2.1. Market size and forecast
4.4.2.3. Cleansing agents
4.4.2.3.1. Market size and forecast
Chapter: 5: PHILIPPINES WOUND CARE MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CHRONIC WOUNDS
5.2.1. Market size and forecast
5.2.1.1. Pressure ulcers
5.2.1.1.1. Market size and forecast
5.2.1.2. Diabetic foot ulcers
5.2.1.2.1. Market size and forecast
5.2.1.3. Venous leg ulcers
5.2.1.3.1. Market size and forecast
5.2.1.4. Arterial ulcers
5.2.1.4.1. Market size and forecast
5.3. ACUTE WOUNDS
5.3.1. Market size and forecast
5.3.1.1. Burns & trauma
5.3.1.1.1. Market size and forecast
5.3.1.2. Surgical wounds
5.3.1.2.1. Market size and forecast
Chapter: 6: PHILIPPINES WOUND CARE MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS
6.2.1. Market size and forecast
6.3. COMMUNITY HEALTH SERVICE CENTERS
6.3.1. Market size and forecast
Chapter: 7: COMPANY PROFILES
7.1. 3M COMPANY
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. CARDINAL HEALTH, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. COLOPLAST A/S
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. CONVATEC GROUP PLC
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. MEDTRONIC PLC. (COVIDIEN LTD.)
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. MUNDIPHARMA INTERNATIONAL LIMITED
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. SMITH & NEPHEW PLC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. SVENSKA CELLULOSA AKTIEBOLAGET (BSN MEDICAL GMBH)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Product portfolio
7.9.4. Business performance
7.10. URGO GROUP (URGO MEDICAL)
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
